Medical Condition News

RSS

Tailored antibody-drug conjugate offers hope for aggressive breast cancer

Scientists have used breast cancer cells' weakness against themselves by linking a tumour-selective antibody with a cell-killing drug to destroy hard-to-treat tumors.

21 May 2024

Study links higher microplastic levels in urine to endometriosis risk

A study in Ecotoxicology and Environmental Safety finds higher levels of microplastics in urine samples from endometriosis patients compared to healthy individuals.

21 May 2024

Global study highlights major health risks: air pollution and high blood pressure top the list

A comprehensive study in The Lancet reveals the global health impacts of 88 risk factors, emphasizing the significant burden of air pollution and high blood pressure.

21 May 2024

New model predicts kidney function recovery after acute kidney injury

Researchers at the University of Cincinnati College of Medicine have created a scoring model that uses key health indicators to accurately predict recovery for patients who experience kidney failure due to acute kidney injury (AKI), which occurs when kidneys stop working properly and can range from minor loss of kidney function to complete failure.

21 May 2024

Cleveland Clinic study reveals significant genetic predisposition in melanoma patients

When it comes to skin cancer, most people think of warnings about sunburn and tanning beds. Thoughts of "cancer genes" or inherited risks are reserved for diseases like breast cancer or colon cancer.

21 May 2024

Eating more potatoes may lower your risk of heart disease and early death, study finds

A Norwegian study found that higher potato consumption moderately reduces the risk of all-cause and cardiovascular disease mortality in adults.

21 May 2024

Understanding the role of oxidative stress in Alzheimer's disease pathogenesis

The number of people suffering from Alzheimer's disease (AD) is expected to reach 100 million by 2050, but there is still no effective therapy.

21 May 2024

Novel therapy reprograms immune cells, shrinks prostate and bladder cancers in animal study

A novel therapy that reprograms immune cells to promote antitumor activity helped shrink hard-to-treat prostate and bladder cancers in mice, according to research from the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy and Johns Hopkins Drug Discovery.

21 May 2024

Exercise enhances efficacy of antibody therapy in leukemia patients

Bouts of moderate-to-vigorous intensity exercise could improve the efficacy of antibody therapies used to treat chronic lymphocytic leukemia, new research has shown.

21 May 2024

Study links nocturnal heat with increased stroke risk

In a recent study, researchers from Helmholtz Munich and the Augsburg University Hospital show that nocturnal heat significantly increases the risk of stroke.

21 May 2024

Key studies on GLP-1 drugs, alpha-gal syndrome, and liver disease medications to be presented at DDW 2024

Studies examining the risks of GLP-1 weight-loss drugs, distinguishing alpha-gal syndrome from other GI disorders, and comparing medications to slow the progression of liver disease in patients with alcohol-use disorder will be presented this week at Digestive Disease Week (DDW) 2024.

21 May 2024

Researchers decipher how immune cells spot cancer's turbocharged metabolism

When cells become tumor cells, their metabolism changes fundamentally. Researchers at the University of Basel and the University Hospital Basel have now demonstrated that this change leaves traces that could provide targets for cancer immunotherapies.

21 May 2024